Back to
Walleye Capital LLC
CRVS
Showing 0 of 3 quarters
Position history for
Walleye Capital LLC's holdings in CORVUS PHARMACEUTICALS INC
No. Walleye Capital exited its CRVS (Corvus Pharmaceuticals) position in Q2 2022. Its Q1 2022 13F listed 15,080 shares worth $25,000. Walleye Capital first reported CRVS in Q4 2021 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.